Ein Business-Meeting (Symbolbild).
Quelle: - © gilaxia / E+ / Getty Images:
Google
PR Newswire  | 

Novavax to Participate in Upcoming March Investor Conferences

PR Newswire

play Anhören
share Teilen
feedback Feedback
copy Kopieren
newsletter
font_big Schrift vergrößern
Novavax Inc 6,815 $ Novavax Inc Chart -0,66%
Zugehörige Wertpapiere:

GAITHERSBURG, Md., Feb. 27, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), today announced that the management team will participate in the following upcoming investor conferences:

TD Cowen 45th Annual Health Care Conference:

Fireside Chat

Date:

Tuesday, March 4, 2025


Time:

9:10 – 9:40 a.m. Eastern Time (ET)


Location:

Boston, MA


 

Conference

Event:

Investor Meetings


Date:

Tuesday, March 4, 2025



Leerink Partners 2025 Global Healthcare Conference:

Presentation

Date:

Tuesday, March 11, 2025


Time:

3:40 – 4:10 p.m. ET


Location:

Miami Beach, FL


 

Conference

Event:

Investor Meetings


Date:

Tuesday, March 11, 2025





Jefferies Biotech on the Beach Summit:

Conference

Event:

Investor Meetings


Date:

Wednesday, March 12, 2025


Location:

 

Miami Beach, FL

A webcast of the fireside chat and presentation will be available through the Events and Presentations page of the Company's website at ir.novavax.com, with replays available for 30 days after the conferences.

About Novavax

Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most significant health challenges by leveraging its scientific expertise in vaccines and its cutting-edge technology platform, including a protein-based nanoparticle and Matrix-M™ adjuvant. The Company's growth strategy is focused on building new and diversified partnerships via the out-licensing of its technology platform and vaccine assets earlier in the development process. These strategic collaborations are fueled by smart investments in a growing early-stage pipeline starting with the Company's core expertise in infectious disease and potentially expanding into other disease areas. Please visit novavax.com and LinkedIn for more information.

Contacts:
Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com

Media
Giovanna Chandler
202-709-5563
media@novavax.com

 

Novavax Logo (PRNewsfoto/Novavax)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-upcoming-march-investor-conferences-302387404.html

SOURCE Novavax, Inc.


Für dich aus unserer Redaktion zusammengestellt

Dein Kommentar zum Artikel im Forum

Jetzt anmelden und diskutieren Registrieren Login

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Weitere Artikel des Autors

Themen im Trend